Informax Q4 Revenues Jump 59 Percent | GenomeWeb

NEW YORK, Feb 7 – Informax said Wednesday its fourth quarter revenues jumped 59 percent to $5.8 million, compared with $3.6 million in the corresponding period in 1999, as the company added six new customers for Genomax.

For 2000, Informax’ revenues were up 71 percent, to $17.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.